GPR85 and lung carcinoma: Next, lung cancer cells transfected with the ACKR2 siRNA or incubated with ACKR2 neutralized antibody markedly abolished CXCL14‐induced cell migration and cell movement, but not CXCR4, and GPR85 (Figure 3F-I and S2A-D).